The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease

European Journal of Clinical Investigation

Volumn 41, Issue 2, 2011, Pages 159-166

  Westerink, Jan ^a   Van Der Graaf, Yolanda ^a   Faber, Daniël R ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Obesity; Thyroid stimulating hormone; Visceral adipose tissue

Indexed keywords

C REACTIVE PROTEIN; THYROTROPIN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SMOKING; SUBCUTANEOUS FAT; THYROTROPIN BLOOD LEVEL; VASCULAR DISEASE;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; THYROTROPIN; YOUNG ADULT;

EID: 78651335954     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02391.x     Document Type: Article

References (28)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
2. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-15.
3. Zamboni M, Armellini F, Turcato E, Micciolo R, Desideri S, Bergamo-Andreis IA et al. Effect of regain of body weight on regional body fat distribution: comparison between pre- and postmenopausal obese women. Obes Res 1996;4:555-60.
4. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-82.
5. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-9.
6. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-9.
7. Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 2000;10:803-8.
8. Fox CS, Pencina MJ, D'Agostino RB, Murabito JM, Seely EW, Pearce EN et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 2008;168:587-92.
9. Asvold BO, Bjoro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med 2008;168:855-60.
10. Haraguchi K, Shimura H, Lin L, Saito T, Endo T, Onaya T. Functional expression of thyrotropin receptor in differentiated 3T3-L1 cells: a possible model cell line of extrathyroidal expression of thyrotropin receptor. Biochem Biophys Res Commun 1996;223:193-8.
11. Nannipieri M, Cecchetti F, Anselmino M, Camastra S, Niccolini P, Lamacchia M et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond) 2009;33:1001-6.
12. Lu M, Lin RY. TSH stimulates adipogenesis in mouse embryonic stem cells. J Endocrinol 2008;196:159-69.
13. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci 2006;47:5197-203.
14. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der GY. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15:773-81.
15. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, Grobbee DE. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 2001;25:1346-51.
16. Asvold BO, Bjoro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med 2007;167:1428-32.
17. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005;90:4019-24.
18. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
19. Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS. Release of 12 Adipokines by Adipose Tissue, Nonfat Cells, and Fat Cells From Obese Women. Obesity (Silver Spring) 2010;18:890-6.
20. Antunes TT, Gagnon A, Chen B, Pacini F, Smith TJ, Sorisky A. Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot. Am J Physiol Endocrinol Metab 2006;290:E1140-4.
21. Antunes TT, Gagnon A, Langille ML, Sorisky A. Thyroid-stimulating hormone induces interleukin-6 release from human adipocytes through activation of the nuclear factor-kappaB pathway. Endocrinology 2008;149:3062-6.
22. Choi SH, Lee YJ, Park YJ, Kim KW, Lee EJ, Lim S et al. Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab 2008;93:2313-8.
23. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 2000;105:1005-11.
24. Ortega FJ, Moreno-Navarrete JM, Ribas V, Esteve E, Rodriguez-Hermosa JI, Ruiz B et al. Subcutaneous Fat Shows Higher Thyroid Hormone Receptor-alpha1 Gene Expression Than Omental Fat. Obesity (Silver Spring) 2009;17:2134-41.
25. van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913-7.
26. Faber DR, van der GY, Westerink J, Visseren FL. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases. Atherosclerosis 2010;212:274-80.
27. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-200.
28. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14.